It's still early, a lot more money yet to be made!

It's still early, a lot more money yet to be made! $ARMAQ Our management team and corporate partners are working to develop a non-toxic and inexpensive low-dose oral formulation of interferon-alpha for the benefit of patients and physicians worldwide.